US agency sees low risk in contaminated blood pressure drugs
August 29, 2019
WASHINGTON (AP) — U.S. health officials on Wednesday tried to reassure patients that they face very low risks from ongoing contamination problems with widely prescribed blood pressure drugs.
Drugmakers have issued more than 50 recalls since last July linked to low levels of a probable cancer-causing chemical found in generic drugs taken by millions of Americans. The contamination underscores the Food and Drug Administration's struggle to police an industry that increasingly relies on overseas manufacturing plants in China and India.
On Wednesday, an FDA official said the actual risk to patient...
For access to this article please
sign in or
subscribe.
Reader Comments(0)